Valuation: Orthofix International NV

Market Cap 363M 316M 299M 272M 507M 34.72B 510M 3.56B 1.38B 17.64B 1.36B 1.33B 56.48B P/E 2026 *
-7.57x
P/E 2027 * -9.42x
Enterprise Value 363M 316M 299M 272M 507M 34.72B 510M 3.56B 1.38B 17.64B 1.36B 1.33B 56.48B EV / Sales 2026 *
0.43x
EV / Sales 2027 * 0.42x
Free-Float
97.83%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 54 07/01/2024
Director of Finance/CFO 55 14/01/2024
Compliance Officer - 31/01/2015
Director TitleAgeSince
Director/Board Member 66 15/03/2016
Director/Board Member 54 07/06/2020
Director/Board Member 64 04/01/2023
Change 5-day change 1-year change 3-year change Capi.($)
+1.33%+0.91% - - 363M
-0.12%-0.99%-23.72%+1.33% 177B
+0.19%+1.50%-1.68%+12.31% 118B
-2.82%-3.49%+7.15%+73.02% 60.78B
-0.26%+3.03%-3.10%-31.30% 49.53B
+1.18%-2.39%+4.57%+35.50% 48.29B
+0.70%+4.07%+15.06%-7.71% 32.96B
-2.68%-0.83% - - 28.94B
+1.31%+6.35%+42.66%-7.22% 25.48B
+1.13%+2.89%+11.87%-22.76% 21.77B
Average +0.04%+0.55%+6.60%+6.64% 62.59B
Weighted average by Cap. -0.12%-0.55%-3.85%+10.03%

Financials

2026 *2027 *
Net sales 851M 741M 701M 637M 1.19B 81.5B 1.2B 8.36B 3.23B 41.42B 3.2B 3.13B 133B 872M 759M 719M 653M 1.22B 83.5B 1.23B 8.56B 3.31B 42.44B 3.28B 3.2B 136B
Net income -42.26M -36.81M -34.84M -31.65M -59.13M -4.05B -59.42M -415M -160M -2.06B -159M -155M -6.58B -43.06M -37.5M -35.49M -32.25M -60.25M -4.12B -60.54M -423M -163M -2.1B -162M -158M -6.71B
Net Debt - -
Logo Orthofix International NV
Orthofix Medical Inc. is a global medical technology company. It offers a comprehensive portfolio of spinal hardware, bone growth therapies, limb reconstruction solutions, biologics and enabling technologies, including the 7D FLASH Navigation System. Its Global Spine segment offers two primary product categories: bone growth therapies and spinal implants, biologics, and enabling technologies. It provides implantable medical devices, biologics, enabling technologies, and other regenerative solutions which aim to restore the quality of life of patients suffering from diseases and traumas of the spine. It offers a variety of treatment solutions that incorporate multiple treatment modalities, such as mechanical, biological, and electromagnetic modes. Its Global Limb Reconstruction segment offers products and solutions for the underserved limb reconstruction market that encompasses four pillars: deformity correction, limb lengthening, complex fracture management, and limb preservation.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!